Antares Capital beefs up loan syndication, sales and trading team with hires

By Iris Dorbian — 3 weeks ago

Antares Capital has made a number of hires to its loan syndication, sales and trading team. Kevin Burke, who is joining Antares from GE Capital, will lead the team that includes managing directors Anthony Diaz, Mark Familo, Erica Frontiero, Peter Nolan, John Timoney and Patrick Wallace. Also, Kristin Condon, a managing director from RBC Capital Markets and Todd Davis, an associate from Capital One, will be joining the team.

Continue

VC-backed Clearside Biomedical files for IPO

By Iris Dorbian — 1 month ago

Alpharetta, Georgia-based Clearside Biomedical Inc, which focuses on treating blinding diseases of the eye, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. However, the company plans on trading the stock on the NASDAQ under the ticker symbol “CLSD.” RBC Capital Markets and Stifel will serve as the lead underwriters. Clearside’s backers include Aju IB Investment, Cormorant Asset Management, Perceptive Advisors and Rock Springs Capital Management.

Continue

Element Partners-backed AquaVenture Holdings files for IPO

By Iris Dorbian — 5 months ago

Tampa-based water purification solutions provider AquaVenture Holdings LLC has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The company plans on trading the stock on the New York Stock Exchange under the ticker symbol “WAAS.” Citigroup, Deutsche Bank Securities and RBC Capital Markets are serving as the lead underwriters. AquaVenture’s backers include Element Partners.

Continue

VC-backed Nabriva Therapeutics goes public

By Iris Dorbian — 5 months ago

Nabriva Therapeutics, a biopharmaceutical company focused on treating serious infections, has unveiled its IPO after pricing its 9 million shares at $10.25 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “NBRV.” Leerink Partners LLC and RBC Capital Markets are serving as the lead underwriters. Nabriva’s backers included Vivo Capital, OrbiMed EcoR1 Capital, HBM, Phase4 Partners, Wellcome Trust, GLSV and Novartis Venture Fund

Continue

JMI Equity-backed PointClickCare files for IPO

By Iris Dorbian — 5 months ago

Ontario-based PointClickCare, a software provider for the senior care industry, has filed for an IPO. The number of shares that will be sold as well as the pricing terms have yet to be set. The company plans on trading the stock on the NASDAQ under the ticker symbol “PCLK” and on the Toronto Stock Exchange under the ticker symbol “PCC.” J.P. Morgan Securities LLC, Goldman Sachs and RBC Capital Markets LLC are serving as the lead underwriters. PointClickCare is backed by JMI Equity.

Continue

Kohlberg buys Osmose

By Iris Dorbian — 6 months ago

Kohlberg and Company LLC has acquired Osmose Utilities Service Inc, a provider of structural integrity management services to power utilities and telecommunications providers across the transmission and distribution infrastructure grid. No financial terms were disclosed. Harris Williams & Co provided financial advice to Osmose on the transaction while RBC Capital Markets did likewise for Kohlberg.

Continue

GTCR to exit AssuredPartners

By Luisa Beltran — 7 months ago

Apax Partners has agreed to buy a majority of AssuredPartners Inc. GTCR is the seller. Assured’s management will have a “significant” equity position, a statement said. Financial terms weren’t announced. BofA Merrill Lynch, RBC Capital Markets and Morgan Stanley Senior Funding Inc. are providing debt funding. Lake Mary, Florida-based AssuredPartners is an independent insurance brokerage.

Continue

Marketing tech platform RadiumOne collects $54 mln

By Iris Dorbian — 8 months ago

San Francisco-based RadiumOne, a marketing technology platform for brands and agencies, has raised $54 million in funding. Harmony Partners led the round with participation from Industry Ventures, Adams Street Partners, Crosslink Capital, Trinity Ventures and DFJ Espirit. RBC Capital Markets served as placement agent for the transaction.

Continue

Apax to buy Quality Distribution for $800 mln

By Luisa Beltran — 9 months ago

Apax Partners has agreed to buy Quality Distribution Inc. in a deal valued at about $800 million, including debt. The transaction includes a 40-day “go-shop” where Quality Distribution can solicit alternative proposals from third parties. Tampa-based Quality Distribution operates a chemical bulk logistics network in North America. Deutsche Bank AG New York Branch, Bank of America N.A., Jefferies Finance LLC, MIHI LLC and SunTrust Bank are providing financing. RBC Capital Markets provided financial advice to Quality Distribution.

Continue

PE-backed Enviva Partners goes public

By Iris Dorbian — 10 months ago

Enviva Partners LP, a wood pellets provider to large power generations, has raised $200 million for its IPO after pricing its 10 million shares at $20 per share. The stock began trading Wednesday on the NYSE under the ticker symbol “EVA.” Barclays Capital Inc, Goldman, Sachs & Co, RBC Capital Markets LLC and Citigroup Global Markets Inc are the lead underwriters. Enviva Partners is backed by Riverstone/Carlyle Renewable Energy Partners.

Continue

NCSG Crane & Heavy Haul Corp to buy PE-owned B&G

By Iris Dorbian — 10 months ago

NCSG Crane & Heavy Haul Corporation and its investor group led by TriWest Capital Partners, Alberta Teachers’ Retirement Fund and NCA Partners have agreed to acquire B&G Crane Holdings. No financial terms were disclosed. Stifel is serving as financial advisor to NCSG on the transaction while RBC Capital Markets is doing likewise to B&G. B&G, which is owned by The Sterling Group LP, is a provider of crane services, specialized rigging and heavy haul transportation in Louisiana and Texas.

Continue

KemPharm goes public

By Iris Dorbian — 10 months ago

Coralville, Iowa-based specialty pharmaceutical company KemPharm Inc has debuted its IPO after pricing its over 5 million shares at $11 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “KMPH.” Cowen and Company and RBC Capital Markets are the lead underwriters. The company’s backers include Deerfield Management.

Continue

EQT to sell RTI to Aurora-led investor group

By Iris Dorbian — 10 months ago

An investor group led by Aurora Capital Group has agreed to acquire Restaurant Technologies Inc from EQT Infrastructure Limited. No financial terms were disclosed. RBC Capital Markets LLC and Weil, Gotshal and Manges LLP advised EQT on the transaction. Based in Minneapolis, RTI is a provider of edible oil management and distribution services to the U.S. food service sector.

Continue

D.A. Davidson names Cummings as MD

By Iris Dorbian — 11 months ago

Investment banking firm D.A. Davidson & Co has appointed Bryan Cummings as managing director and head of private equity coverage. Cummings’ previous work experience includes senior level roles at RBC Capital Markets and an unnamed information services firm.

Continue

VC-backed SteadyMed sets IPO pricing terms

By Iris Dorbian — 11 months ago

SteadyMed Ltd, a specialty pharmaceutical company based in San Ramon, California and Israel, has priced its IPO of 4.25 million shares at between $12 and $14 per share. SteadyMed plans on listing the stock on the NASDAQ under the ticker symbol “STDY.” Wells Fargo Securities LLC and RBC Capital Markets LLC are the lead underwriters. SteadyMed’s backers include Samson Venture Partners, Deerfield Management and Federated Investors.

Continue

NGL Energy Partners to acquire PE-backed Magnum for $280 mln

By Iris Dorbian — 1 year ago

NGL Energy Partners has agreed to buy Haddington Ventures-backed Magnum NGLs LLC, which owns and operates a natural gas liquids storage facility in Utah. The estimated price of the acquisition is $280 million. RBC Capital Markets LLC is providing financial advice to NGL on the transaction while Simmons & Company International is acting as financial advisor to Magnum Development and Haddington Ventures.

Continue

VC-backed Infraredx sets IPO pricing terms

By Iris Dorbian — 1 year ago

Burlington, Massachusetts-based Infraredx, a cardiovascular imaging firm, has priced its IPO of 4 million shares at between $13 and $15 a share. The stock will trade on the NASDAQ under the ticker symbol “REDX.” RBC Capital Markets LLC Canaccord Genuity Inc and BMO Capital Markets Corp are serving as lead underwriters. Its backers include Sanderling Ventures, Nipro Corp. and Eastwood Capital.

Continue